PULIKE BIOLOGICAL ENGINEERING，INC. revenue breakdown overview

PULIKE BIOLOGICAL ENGINEERING，INC. revenue for the last year amounted to 1.25 B CNY, the most of which — 434.28 M CNY — came from its highest performing source at the moment, Pig Vaccines, the year earlier bringing 461.60 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought PULIKE BIOLOGICAL ENGINEERING，INC. 1.23 B CNY, and the year before that — 1.20 B CNY.